Lupus & antiphospholipid syndrome

Macrophage activation syndrome in systemic lupus erythematous and Still’s disease: distinct phenotypes shaped by the underlying diseases

Rheumatology (Oxford)Published Retrospective cohort study

Authors' conclusion

SLE-MAS diverged from SD-MAS with less organomegaly and liver injury but more pronounced CNS involvement and hematological involvement, the latter strongly linked to red blood cell directed autoantibodies.

Study context

Population
Adults with a history of SLE-MAS or SD-MAS, eight tertiary referral centres
Exposure
SLE-MAS vs SD-MAS
Outcome
MAS clinical/laboratory features, treatments and outcomes compared between SLE-MAS and SD-MAS
Methodological detailsmulticentre, eight tertiary referral centres, exploratory multivariable profiling, comparison with historical SLE cohorts
  • Multicentre
  • Eight tertiary referral centres
  • Exploratory multivariable profiling
  • Comparison with historical SLE cohorts

Main finding

As reported in the abstract

MAS clinical/laboratory features

Meeting 2016 ACR/EULAR/PRINTO criteria

OutcomeSLE-MASSD-MAS
Direct Coombs (DCT) positivity73%— not stated in the abstract

— not stated in the abstract

Observational data: associations, not effects.

Further findings

OutcomeValues
IL-1 antagonism in SLE-MASSLE-MAS 7 events

IL-1 antagonism in SLE-MAS

Mixed results without any rapid macrophage activation syndrome (MAS) resolution

SLE-MAS vs historical SLE cohorts (1000, 2228 and 2055 cases)

Mucocutaneous disease, autoimmune haemolysis, CNS involvement, less pronounced female preponderance and much higher DCT positivity dominated the SLE-MAS phenotype

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Macrophage activation syndrome in systemic lupus erythematous and Still’s disease: distinct phenotypes shaped by the underlying diseases. Rheumatology (Oxford). Published 11 September 2026. doi:10.1093/rheumatology/keag490

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.